Developer docs
API playgroundTry for free, no card

Search company profiles

Kreussler & Co.

Full company profile

uuid000wark

Namestring
Kreussler & Co.
Legal namestring
Chemische Fabrik Kreussler & Co. GmbH
Company typeenum
Private
Founded yearint
1948
Descriptiontext

Kreussler & Co. (doing business as Kreussler Pharma) is a privately held German pharmaceutical manufacturer founded in 1948 and headquartered in Wiesbaden, Germany. The company is family-owned in its fourth generation, with more than 75 years of pharmaceutical manufacturing experience and a business heritage stretching back over 110 years. It develops, produces, and markets over-the-counter (OTC) pharmaceutical preparations concentrated in four therapeutic areas: oral healthcare, phlebology (vein disorders), proctology, and muscle/joint-related relaxation.

Its product portfolio includes branded OTC preparations such as DYNEXAN MUNDGEL, DYNEXIDIN FORTE, DEQUONAL, RECESSAN, DYNEXAMINFLUORID, Aethoxysklerol, and Phardol Thermo. All manufacturing is conducted at the company's Wiesbaden site. The company serves two primary customer segments: healthcare professionals (dentists, phlebologists, proctologists, general practitioners) and end consumers reached through pharmacies and dental channels. Its commercial model relies on prescription and OTC sales via pharmacy, dental, and selected distribution-partner channels; this is illustrated by the June 2026 partnership with Dermavon (德镒医药) to bring its portfolio into the Chinese market.

Geographically, more than two-thirds of revenue is generated outside Germany, with products distributed in over 70 countries. The workforce is stable — approximately 50% of employees have ten or more years of tenure — consistent with the operational profile of a mature, family-governed specialty pharmaceutical manufacturer.

Short descriptiontext

Kreussler Pharma is a privately held, fourth-generation German pharmaceutical manufacturer producing OTC preparations in oral healthcare, phlebology, proctology, and muscle relaxation, distributed across more than 70 countries from its Wiesbaden production site.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWiesbaden, Germany
HQ citystring
Wiesbaden
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
OTC pharmaceuticals, oral healthcare products, sclerosing agents, phlebology treatments, proctology products
Industry2 codes
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
OTC Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Products (OTC Preparations)
TypeOne Time License
Description

Sale of over-the-counter pharmaceutical preparations including oral health products (Dynexan Mundgel, Dequonal, Dynexidin Forte, Dynexaminfluorid Gelée), sclerosing agents (Aethoxysklerol), and other therapeutic products. Revenue is generated through pharmacy sales, direct healthcare professional sales, and international distribution via subsidiaries and partners. Over two-thirds of revenue is generated abroad.

kreussler-pharma.de
2Medical Devices and Cosmetics
TypeOne Time License
Description

Sale of medical devices and cosmetics in the oral healthcare, phlebology and proctology segments. These products complement the pharmaceutical portfolio and are sold through similar distribution channels including pharmacies and healthcare professionals.

kreussler-pharma.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Dynexan
Description

Oral health product line including Dynexan Mundgel (pain-relieving gel), Dynexidin Forte (mouthwash), and related oral care products

kreussler-pharma.de
+5 more records
Core offering1 text field

Chemische Fabrik Kreussler & Co. GmbH (Kreussler Pharma) develops, produces and sells over-the-counter pharmaceutical preparations, medical devices and cosmetics in three therapeutic areas: oral healthcare (pain gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for spider veins, varicose veins and haemorrhoids), and movement/relaxation. Products are manufactured almost exclusively at the Wiesbaden site and distributed through pharmacies, direct healthcare professional channels, and international subsidiaries/sales partners across 70+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Sclerotherapy with Aethoxysklerol achieves improvement rates of over 90% for spider veins and smaller varicose veins per medical guidelines
+2 more records
Product overview1 text field

Kreussler Pharma is a pharmaceutical company offering a portfolio of OTC preparations organized into three therapeutic areas: oral healthcare (pain relief gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for vein treatment), and proctology. The core oral health products include DYNEXAN MUNDGEL® (lidocaine-based pain gel), DYNEXIDIN® FORTE (chlorhexidine mouthwash), DEQUONAL® (antiseptic solution), RECESSAN® (polidocanol ointment), and DYNEXAMINFLUORID preparations (fluoride gel and varnish). For movement and relaxation, Phardol® Thermo provides warming relief. The phlebology/proctology portfolio centers on Aethoxysklerol®, a sclerosing agent available in multiple concentrations for treating spider veins, varicose veins, haemorrhoids, and oesophageal varices. Products are distributed internationally through own subsidiaries and sales partners, with production almost exclusively at the Wiesbaden site.

Product and service9 records
1DYNEXAN MUNDGEL
CategoryOral healthcare pharmaceuticals
Description

Pain-relieving oral gel containing lidocaine hydrochloride 20mg for temporary, symptomatic treatment of pain in oral mucosa, gums, and lips. Also available in cylinder ampoule form for intra-pocket anaesthesia without injection. Sold to consumers via pharmacies and to dental professionals for clinical use.

2DYNEXIDIN FORTE
CategoryOral healthcare pharmaceuticals
Description

Chlorhexidine-based mouthwash (0.2%) for temporary reduction of bacteria in the oral cavity and supportive treatment of bacterial inflammation of gums and oral mucosa. Sold OTC through pharmacies.

3DEQUONAL
CategoryOral healthcare pharmaceuticals
Description

Mouthwash and spray containing dequalinium chloride and benzalkonium chloride, effective against various viruses, bacteria and fungi for supportive treatment of oral mucosa inflammation and bad breath. Sold OTC through pharmacies.

4RECESSAN
CategoryOral healthcare pharmaceuticals
Description

Highly adhesive analgesic ointment containing lauromacrogol 400 (polidocanol) 30mg for temporary, symptomatic treatment of painful inflammatory conditions of gums and oral mucosa. Sold OTC through pharmacies.

5DYNEXAMINFLUORID GELÉE
CategoryDental prophylaxis pharmaceuticals
Description

Dental gel containing olaflur, dectaflur and sodium fluoride (1.25% total fluoride) for caries prevention, initial caries treatment, and treatment of hypersensitive tooth necks. Awarded Dental Growth Champion 2025.

6DYNEXAMINFLUORID LACK
CategoryDental prophylaxis pharmaceuticals
Description

Fluoride varnish with four-way fluoridation for dental prophylaxis and caries protection, applied by dental professionals.

7DYNEXAN MUNDGEL Cylinder Ampoules
CategoryOral healthcare pharmaceuticals
Description

Intra-pocket anaesthesia format of DYNEXAN MUNDGEL for pain-free dental procedures without injection, used by dental professionals during closed periodontal treatment.

8Phardol Thermo
CategoryMovement and relaxation topicals
Description

Topical product for exercise and relaxation providing soothing warmth to support muscle regeneration and enhance well-being. Sold OTC through pharmacies.

9Aethoxysklerol
CategoryPhlebology and proctology pharmaceuticals
Description

Sclerosing agent solution (0.25%, 0.5%, 1%, 2%, 3%) for sclerotherapy treatment of spider veins, varicose veins, haemorrhoids, and oesophageal varices. Causes vessel sealing and shrinkage through tissue reaction. Used by healthcare professionals (phlebologists, vascular surgeons, proctologists).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Dermavon (德镁医药)
Strategic tierNotableTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-01
Description

Dermavon is Kreussler Pharma's long-standing partner for the Chinese market. Dr. Philipp Göbel, Managing Director, travelled with Dermavon representatives to visit Shenyang, Beijing, Tianjin and Shanghai, meeting leading physicians including professors at Peking University hospitals and the Plastic Surgery Hospital of the Chinese Academy of Medical Science. Discussions focused on Aethoxysklerol's use for venous disease and haemorrhoid treatment in China. This partnership enables market presence in one of the world's most dynamic healthcare markets.

kreussler-pharma.de
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global pure-play dermatology and aesthetics pharmaceutical company covering prescription, OTC and aesthetic products. Overlaps with Kreussler's dermatology/aesthetics sclerosing agents and topical formulations, but at much larger scale and with broader portfolio.

TypeDirect peer
Description

German specialty pharmaceutical company focused on branded OTC and prescription products in dermatology, allergy and women's health, with strong pharmacy distribution. Highly comparable to Kreussler as a mid-size German branded pharma operator selling OTC through pharmacies.

TypeDirect peer
Description

German mid-size pharma manufacturer specialising in branded prescription and OTC products including phytopharmaceuticals and specialty preparations. Comparable as a similarly sized German specialty pharma with branded portfolio and pharmacy distribution.

TypeBroad incumbent
Description

Global consumer healthcare leader in oral health (Sensodyne, Corsodyl/chlorhexidine, Aquafresh), pain relief and wellness. Directly relevant via Corsodyl (chlorhexidine mouthwash competing with Dynexidin Forte/Dequonal) and broader OTC oral-care franchise.

TypeOthers
Description

Global leader in medical compression therapy for venous and lymphatic disease. Adjacent to Kreussler's phlebology franchise (Aethoxysklerol sclerotherapy) — a complementary rather than directly competing channel in vein care.

TypeDirect peer
Description

Independent German family-owned pharma specialising in gynecology, dermatology and OTC self-medication. Comparable in family-ownership model, German manufacturing footprint and branded OTC/women's health focus.

TypeBroad incumbent
Description

Germany-headquartered pharmaceutical company with a large branded OTC and generics portfolio across many therapeutic areas. Comparable to Kreussler via its German pharma heritage and pharmacy-channel OTC model, though significantly larger and broader in product mix.

TypeDirect peer
Description

Mid-size German family/pharmaceutical-owned manufacturer of branded OTC and Rx products in cardiology, dermatology and women's health. Closely comparable in size, German mid-market positioning and branded OTC specialty model.

TypeBroad incumbent
Description

Global pharmaceutical major with significant proctology (Preparation H) and broader consumer health OTC offerings. Comparable as an established branded OTC participant in the haemorrhoid category where Aethoxysklerol is registered.

TypeDirect peer
Description

German mid-size pharmaceutical company developing and producing branded OTC and Rx products for self-medication and women's health. Directly comparable as a German specialty pharma manufacturer serving pharmacy channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kreussler & Co.

OTC Pharmaceuticalskreussler-pharma.de

Kreussler Pharma is a privately held, fourth-generation German pharmaceutical manufacturer producing OTC preparations in oral healthcare, phlebology, proctology, and muscle relaxation, distributed across more than 70 countries from its Wiesbaden production site.

What Kreussler & Co. does

Kreussler & Co. (doing business as Kreussler Pharma) is a privately held German pharmaceutical manufacturer founded in 1948 and headquartered in Wiesbaden, Germany. The company is family-owned in its fourth generation, with more than 75 years of pharmaceutical manufacturing experience and a business heritage stretching back over 110 years. It develops, produces, and markets over-the-counter (OTC) pharmaceutical preparations concentrated in four therapeutic areas: oral healthcare, phlebology (vein disorders), proctology, and muscle/joint-related relaxation.

Its product portfolio includes branded OTC preparations such as DYNEXAN MUNDGEL, DYNEXIDIN FORTE, DEQUONAL, RECESSAN, DYNEXAMINFLUORID, Aethoxysklerol, and Phardol Thermo. All manufacturing is conducted at the company's Wiesbaden site. The company serves two primary customer segments: healthcare professionals (dentists, phlebologists, proctologists, general practitioners) and end consumers reached through pharmacies and dental channels. Its commercial model relies on prescription and OTC sales via pharmacy, dental, and selected distribution-partner channels; this is illustrated by the June 2026 partnership with Dermavon (德镒医药) to bring its portfolio into the Chinese market.

Geographically, more than two-thirds of revenue is generated outside Germany, with products distributed in over 70 countries. The workforce is stable — approximately 50% of employees have ten or more years of tenure — consistent with the operational profile of a mature, family-governed specialty pharmaceutical manufacturer.

Kreussler & Co. firmographics

Firmographics
Name
Kreussler & Co.
Legal name
Chemische Fabrik Kreussler & Co. GmbH
Website
https://kreussler-pharma.de
Company type
Private
Founded year
1948
Operating status
Operating
Headcount range
11–50 employees
Short description
Kreussler Pharma is a privately held, fourth-generation German pharmaceutical manufacturer producing OTC preparations in oral healthcare, phlebology, proctology, and muscle relaxation, distributed across more than 70 countries from its Wiesbaden production site.
Ownership category
akta.pro rank

Kreussler & Co. industry classification

Industry
Product category
OTC Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • OTC pharmaceuticals
  • Oral healthcare products
  • Sclerosing agents
  • Phlebology treatments
  • Proctology products

Where Kreussler & Co. is headquartered

Location

Headquarters

HQ city
Wiesbaden
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Kreussler & Co. business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Products (OTC Preparations): Sale of over-the-counter pharmaceutical preparations including oral health products (Dynexan Mundgel, Dequonal, Dynexidin Forte, Dynexaminfluorid Gelée), sclerosing agents (Aethoxysklerol), and other therapeutic products. Revenue is generated through pharmacy sales, direct healthcare professional sales, and international distribution via subsidiaries and partners. Over two-thirds of revenue is generated abroad.
  2. Medical Devices and Cosmetics: Sale of medical devices and cosmetics in the oral healthcare, phlebology and proctology segments. These products complement the pharmaceutical portfolio and are sold through similar distribution channels including pharmacies and healthcare professionals.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Kreussler & Co. product offering

Product offering

Core offering

Chemische Fabrik Kreussler & Co. GmbH (Kreussler Pharma) develops, produces and sells over-the-counter pharmaceutical preparations, medical devices and cosmetics in three therapeutic areas: oral healthcare (pain gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for spider veins, varicose veins and haemorrhoids), and movement/relaxation. Products are manufactured almost exclusively at the Wiesbaden site and distributed through pharmacies, direct healthcare professional channels, and international subsidiaries/sales partners across 70+ countries.

Product overview

Kreussler Pharma is a pharmaceutical company offering a portfolio of OTC preparations organized into three therapeutic areas: oral healthcare (pain relief gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for vein treatment), and proctology. The core oral health products include DYNEXAN MUNDGEL® (lidocaine-based pain gel), DYNEXIDIN® FORTE (chlorhexidine mouthwash), DEQUONAL® (antiseptic solution), RECESSAN® (polidocanol ointment), and DYNEXAMINFLUORID preparations (fluoride gel and varnish). For movement and relaxation, Phardol® Thermo provides warming relief. The phlebology/proctology portfolio centers on Aethoxysklerol®, a sclerosing agent available in multiple concentrations for treating spider veins, varicose veins, haemorrhoids, and oesophageal varices. Products are distributed internationally through own subsidiaries and sales partners, with production almost exclusively at the Wiesbaden site.

Differentiator

Problem solved

Functional benefit

Brands

  • Dynexan: Oral health product line including Dynexan Mundgel (pain-relieving gel), Dynexidin Forte (mouthwash), and related oral care products
  • Aethoxysklerol
  • Dequonal
  • Recessan
  • Dynexaminfluorid
  • Phardol Thermo

Products and services

  • DYNEXAN MUNDGEL Pain-relieving oral gel containing lidocaine hydrochloride 20mg for temporary, symptomatic treatment of pain in oral mucosa, gums, and lips. Also available in cylinder ampoule form for intra-pocket anaesthesia without injection. Sold to consumers via pharmacies and to dental professionals for clinical use.
  • DYNEXIDIN FORTE Chlorhexidine-based mouthwash (0.2%) for temporary reduction of bacteria in the oral cavity and supportive treatment of bacterial inflammation of gums and oral mucosa. Sold OTC through pharmacies.
  • DEQUONAL Mouthwash and spray containing dequalinium chloride and benzalkonium chloride, effective against various viruses, bacteria and fungi for supportive treatment of oral mucosa inflammation and bad breath. Sold OTC through pharmacies.
  • RECESSAN Highly adhesive analgesic ointment containing lauromacrogol 400 (polidocanol) 30mg for temporary, symptomatic treatment of painful inflammatory conditions of gums and oral mucosa. Sold OTC through pharmacies.
  • DYNEXAMINFLUORID GELÉE Dental gel containing olaflur, dectaflur and sodium fluoride (1.25% total fluoride) for caries prevention, initial caries treatment, and treatment of hypersensitive tooth necks. Awarded Dental Growth Champion 2025.
  • DYNEXAMINFLUORID LACK Fluoride varnish with four-way fluoridation for dental prophylaxis and caries protection, applied by dental professionals.
  • DYNEXAN MUNDGEL Cylinder Ampoules Intra-pocket anaesthesia format of DYNEXAN MUNDGEL for pain-free dental procedures without injection, used by dental professionals during closed periodontal treatment.
  • Phardol Thermo Topical product for exercise and relaxation providing soothing warmth to support muscle regeneration and enhance well-being. Sold OTC through pharmacies.
  • Aethoxysklerol Sclerosing agent solution (0.25%, 0.5%, 1%, 2%, 3%) for sclerotherapy treatment of spider veins, varicose veins, haemorrhoids, and oesophageal varices. Causes vessel sealing and shrinkage through tissue reaction. Used by healthcare professionals (phlebologists, vascular surgeons, proctologists).

Quantifiable outcome

  • Sclerotherapy with Aethoxysklerol achieves improvement rates of over 90% for spider veins and smaller varicose veins per medical guidelines
  • +2 more outcomes

Companies that use Kreussler & Co.

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Kreussler & Co. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature8 records

Kreussler & Co. partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Dermavon (德镁医药)notableChannel Partner/ Reseller/ Distributor · 1 June 2026Dermavon is Kreussler Pharma's long-standing partner for the Chinese market. Dr. Philipp Göbel, Managing Director, travelled with Dermavon representatives to visit Shenyang, Beijing, Tianjin and Shanghai, meeting leading physicians including professors at Peking University hospitals and the Plastic Surgery Hospital of the Chinese Academy of Medical Science. Discussions focused on Aethoxysklerol's use for venous disease and haemorrhoid treatment in China. This partnership enables market presence in one of the world's most dynamic healthcare markets.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Kreussler & Co. competitors and assessment

Company assessment

Broad incumbents

  • Galderma SA: Global pure-play dermatology and aesthetics pharmaceutical company covering prescription, OTC and aesthetic products. Overlaps with Kreussler's dermatology/aesthetics sclerosing agents and topical formulations, but at much larger scale and with broader portfolio.
  • Haleon plc: Global consumer healthcare leader in oral health (Sensodyne, Corsodyl/chlorhexidine, Aquafresh), pain relief and wellness. Directly relevant via Corsodyl (chlorhexidine mouthwash competing with Dynexidin Forte/Dequonal) and broader OTC oral-care franchise.
  • Stada Arzneimittel AG: Germany-headquartered pharmaceutical company with a large branded OTC and generics portfolio across many therapeutic areas. Comparable to Kreussler via its German pharma heritage and pharmacy-channel OTC model, though significantly larger and broader in product mix.
  • Pfizer Inc. (Consumer Healthcare / Preparation H): Global pharmaceutical major with significant proctology (Preparation H) and broader consumer health OTC offerings. Comparable as an established branded OTC participant in the haemorrhoid category where Aethoxysklerol is registered.

Direct peers

  • Dermapharm Holding SE: German specialty pharmaceutical company focused on branded OTC and prescription products in dermatology, allergy and women's health, with strong pharmacy distribution. Highly comparable to Kreussler as a mid-size German branded pharma operator selling OTC through pharmacies.
  • Repha GmbH Biologische Arzneimittel: German mid-size pharma manufacturer specialising in branded prescription and OTC products including phytopharmaceuticals and specialty preparations. Comparable as a similarly sized German specialty pharma with branded portfolio and pharmacy distribution.
  • Dr. August Wolff GmbH & Co. KG Arzneimittel: Independent German family-owned pharma specialising in gynecology, dermatology and OTC self-medication. Comparable in family-ownership model, German manufacturing footprint and branded OTC/women's health focus.
  • Trommsdorff GmbH & Co. KG: Mid-size German family/pharmaceutical-owned manufacturer of branded OTC and Rx products in cardiology, dermatology and women's health. Closely comparable in size, German mid-market positioning and branded OTC specialty model.
  • Mibe GmbH Arzneimittel: German mid-size pharmaceutical company developing and producing branded OTC and Rx products for self-medication and women's health. Directly comparable as a German specialty pharma manufacturer serving pharmacy channels.

Others

  • SIGVARIS Group: Global leader in medical compression therapy for venous and lymphatic disease. Adjacent to Kreussler's phlebology franchise (Aethoxysklerol sclerotherapy) — a complementary rather than directly competing channel in vein care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Kreussler & Co. social profiles

Digital presence

Kreussler & Co. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kreussler & Co. leadership team

Management profile

Number of profiles

Profiles6 records

Kreussler & Co. subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Kreussler & Co. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kreussler & Co. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kreussler & Co.

What does Kreussler & Co. do?

Chemische Fabrik Kreussler & Co. GmbH (Kreussler Pharma) develops, produces and sells over-the-counter pharmaceutical preparations, medical devices and cosmetics in three therapeutic areas: oral healthcare (pain gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for spider veins, varicose veins and haemorrhoids), and movement/relaxation. Products are manufactured almost exclusively at the Wiesbaden site and distributed through pharmacies, direct healthcare professional channels, and international subsidiaries/sales partners across 70+ countries.

Is Kreussler & Co. a public or private company?

Kreussler & Co. is a private company. It is classified as family owned and is currently operating.

When was Kreussler & Co. founded?

Kreussler & Co. was founded in 1948. It employs 11 to 50 people.

Where is Kreussler & Co. based?

Kreussler & Co. is headquartered in Wiesbaden, Germany, in the Europe region.

How does Kreussler & Co. make money?

Two revenue lines are on record. Pharmaceutical Products (OTC Preparations) is the primary driver. The others are medical Devices and Cosmetics.

Who are Kreussler & Co.'s main competitors?

Broad incumbents on record are Galderma SA, Haleon plc, Stada Arzneimittel AG and Pfizer Inc. (Consumer Healthcare / Preparation H). Direct peers are Dermapharm Holding SE, Repha GmbH Biologische Arzneimittel, Dr. August Wolff GmbH & Co. KG Arzneimittel, Trommsdorff GmbH & Co. KG and Mibe GmbH Arzneimittel. SIGVARIS Group is listed as an others.

Does Kreussler & Co. have an API?

No public API is recorded for Kreussler & Co..

What industry is Kreussler & Co. in?

Kreussler & Co.'s product category is OTC Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales